Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $2.38 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.